Nevertheless, in a study analyzing the effect of PD-1/PD-L1 blockade in this type of tumor, an objective response was reported in 87% of patients enrolled, including 17% with a complete response and 70% with a partial response [45]. The gene discussed is PDCD1; the disease is neoplasm.